Evaluation of the Targeting and Therapeutic Efficiency of Anti-EGFR Functionalised Nanoparticles in Head and Neck Cancer Cells for Use in NIR-II Optical Window. (2021)
Attributed to:
Engineering Therapeutic Microbubbles
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13101651
PubMed Identifier: 34683944
Publication URI: http://europepmc.org/abstract/MED/34683944
Type: Journal Article/Review
Volume: 13
Parent Publication: Pharmaceutics
Issue: 10
ISSN: 1999-4923